Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Newman

Showing results (1-10 of 277) with videos related to

Pageof 28
Sort By:
Journal of Medical Ethics|July 16, 2020
Genetic testing in the acute setting: a round table discussionWilliam G Newman
Annals of Clinical Biochemistry|July 8, 2011
Pharmacogenetics and pharmacogenomics: a clinical realityRoberta Ferraldeschi, William G Newman
Annals of the Rheumatic Diseases|October 15, 2015
Response to: 'Mutation in MMP2 gene may result in scleroderma-like skin thickening' by Bader-Meunier et alSiddharth Banka, William G Newman
Pharmacogenomics|April 21, 2012
Breast cancer pharmacogenomics: where we are goingWilliam G Newman, Dave Flockhart
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
The Impact of CYP2D6 Genotyping on Tamoxifen TreatmentRoberta Ferraldeschi, William G Newman
Orphanet Journal of Rare Diseases|June 14, 2013
A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutationsSiddharth Banka, William G Newman
Clinical Medicine (London, England)|July 5, 2020
Refusal of viral testing during the SARS-CoV-2 pandemicJohn H McDermott, William G Newman
JAMA Pediatrics|June 21, 2022
Options for Detecting Risk of Aminoglycoside-Induced Ototoxicity in Neonates-ReplyJohn H McDermott, William G Newman
Genes|November 11, 2014
Delivery of a clinical genomics serviceWilliam G Newman, Graeme C Black
Pharmacogenomics|April 21, 2012
Pharmacogenetics of aromatase inhibitorsKristen D Hadfield, William G Newman
Pageof 28

Showing results (1-10 of 277) with videos related to

Sort By:
Pageof 28
Journal of Medical Ethics|July 16, 2020
Genetic testing in the acute setting: a round table discussionWilliam G Newman
Annals of Clinical Biochemistry|July 8, 2011
Pharmacogenetics and pharmacogenomics: a clinical realityRoberta Ferraldeschi, William G Newman
Annals of the Rheumatic Diseases|October 15, 2015
Response to: 'Mutation in MMP2 gene may result in scleroderma-like skin thickening' by Bader-Meunier et alSiddharth Banka, William G Newman
Pharmacogenomics|April 21, 2012
Breast cancer pharmacogenomics: where we are goingWilliam G Newman, Dave Flockhart
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
The Impact of CYP2D6 Genotyping on Tamoxifen TreatmentRoberta Ferraldeschi, William G Newman
Orphanet Journal of Rare Diseases|June 14, 2013
A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutationsSiddharth Banka, William G Newman
Clinical Medicine (London, England)|July 5, 2020
Refusal of viral testing during the SARS-CoV-2 pandemicJohn H McDermott, William G Newman
JAMA Pediatrics|June 21, 2022
Options for Detecting Risk of Aminoglycoside-Induced Ototoxicity in Neonates-ReplyJohn H McDermott, William G Newman
Genes|November 11, 2014
Delivery of a clinical genomics serviceWilliam G Newman, Graeme C Black
Pharmacogenomics|April 21, 2012
Pharmacogenetics of aromatase inhibitorsKristen D Hadfield, William G Newman
Pageof 28